Peregrine Pharmaceuticals

Steven W. King,
President and CEO, Director
Paul J. Lytle,
Chief Financial Officer
Joseph S. Shan, M.P.H.,
Vice President, Clinical & Regulatory Affairs
Shelley P. M. Fussey, Ph.D,.
Vice President, Intellectual Property
Jeffrey L. Masten,
Vice President, Quality
Mark R. Ziebell, Esq.,
Vice President, General Counsel and Corporate Secretary
Jeff T. Hutchins, Ph.D.,
Vice President, Preclinical Research
Robert L. Garnick, Ph.D.,
Head of Regulatory Affairs
Kerstin B. Menander, M.D., Ph.D.,
Head of Medical Oncology
Mary J. Boyd, Ph.D.,
Head of Business Development for Asia and Europe

President and CEO, Director
David H. Poh,l
Director
Eric S. Swartz,
Director